Supplier profile
PROTEOGENIX
Every public-sector award we hold for this supplier, across France and the United States, from 26 Apr 2012 to 3 Jun 2026.
Awards won
13
all time
Attributed value
$124k
7 shared, unvalued
Buyers
8
public bodies
Active
2012–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| National Institutes of Health | 5 | $124k |
| UNIVERSITE DE CAEN NORMANDIE | 2 | not attributable |
| AP-HM | 1 | not attributable |
| CHU d'Angers | 1 | not attributable |
| CHU de Dijon | 1 | not attributable |
| Université de Strasbourg | 1 | not attributable |
| université de Strasbourg | 1 | not attributable |
| Établissement français du sang | 1 | not attributable |
What they win
Awards
All 13 awards we hold
- France – Research and development services and related consultancy services – Prestation de génération d’anticorps monoclonaux ↗UNIVERSITE DE CAEN NORMANDIEshared awardawarded 3 Jun 2026
- Prestation de génération d’anticorps monoclonaux ↗UNIVERSITE DE CAEN NORMANDIEawarded 2 Jun 2026
- [25-012037] Nhlbi Cellular And Molecular Therapeutics Laboratory Requires The Phage Library In Order To Perform Upcoming Experiments In Genetic Analysis. Our Laboratory Is Focused On Developing Hematopoietic Stem Cell (Hsc) Therapy With Gene Modifica ↗National Institutes of Health£22kawarded 3 Sept 2025
- [25-013787] Nhlbi Cellular And Molecular Therapeutics Laboratory Requires The Phage Library In Order To Perform Upcoming Experiments In Genetic Analysis. Our Laboratory Is Focused On Developing Hematopoietic Stem Cell (Hsc) Therapy With Gene Modifica ↗National Institutes of Health£15kawarded 3 Sept 2025
- [25-000153] Nih Nhlbi Dir Cmtb Laboratory Requires Additional Results From A Previous Screening Service In Order To Perform Upcoming Experiments In The Development Of Novel Gene Therapy. ↗National Institutes of Health£11kawarded 18 Oct 2024
- Phage-Display Vhh Antibody Screening Service To Develop In Vivo Gene Therapy ↗National Institutes of Health£30kawarded 19 Aug 2024
- Phage-Display Library Screening Services To Develop In Vivo Gene Therapy. ↗National Institutes of Health£46kawarded 12 Apr 2024
- France-Strasbourg: Laboratory services ↗université de Strasbourgshared awardawarded 12 May 2023
- Création et fourniture d'anticorps à façon et services associés pour le compte de l'Université de Strasbourg (relance) ↗Université de Strasbourgshared awardawarded 11 May 2023
- Anticorps monoclonaux pour cytométrie de flux; anticorps monoclonaux; immunoglobulines humaines et animales; cytokines et facteurs de croissance; dosages de cytokines et facteurs croissance divers ↗AP-HMshared awardawarded 16 Jun 2016
- Lot attribué: n° 6. Montant susceptible de varier de + ou - 20 % en valeur ↗CHU de Dijonshared awardawarded 19 Feb 2015
- Ac murin anti CD45 humain marqué FITC ↗Établissement français du sangshared awardawarded 17 Sept 2014
- Lots 806-955-1055. ↗CHU d'Angersshared awardawarded 26 Apr 2012
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.